Literature DB >> 27473181

Role of per-oral pancreatoscopy in the evaluation of suspected pancreatic duct neoplasia: a 13-year U.S. single-center experience.

Ihab I El Hajj1, Brian C Brauer2, Sachin Wani2, Norio Fukami3, Augustin R Attwell2, Raj J Shah2.   

Abstract

BACKGROUND AND AIMS: The role of per-oral pancreatoscopy (POP) in the evaluation of occult pancreatic duct (PD) lesions remains limited to case series. The aim of this study was to evaluate the ability of POP to differentiate malignant from benign diseases of the PD.
METHODS: Patients who underwent POP between 2000 and 2013 for the evaluation of indeterminate PD strictures, dilatations, or with suspected or known main duct intraductal papillary mucinous neoplasm were identified. Main outcome measurements were visual impression accuracy, POP tissue sampling, efficacy, and safety of POP.
RESULTS: During the study period, 79 patients who underwent POP for the evaluation of pancreatic stricture or dilatation were identified. Technical success was achieved in 78 (97%). In the PD neoplasia group (n = 33), the final diagnosis was based on index confirmatory POP-guided tissue sampling in 29 (88%). For the detection of PD neoplasia, POP visual impression had a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 87%, 86%, 83%, 91%, and 87%, respectively. When combined with POP-guided tissue sampling, the values were 91%, 95%, 94%, 93%, and 94%, respectively. Of 102 POPs performed, adverse events were noted in 12 (12%) cases.
CONCLUSIONS: This study demonstrates a high technical success rate, visual impression accuracy, and tissue sampling capability of POP. Examinations were performed by endoscopists with expertise in pancreatoscopy interpretation, and the results may not be generalizable.
Copyright © 2017 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27473181     DOI: 10.1016/j.gie.2016.07.040

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  7 in total

Review 1.  Current Status and Future Perspective in Cholangiopancreatoscopy.

Authors:  Yusuke Ishida; Takao Itoi; Yoshinobu Okabe
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

Review 2.  Indications for Single-Operator Cholangioscopy and Pancreatoscopy: an Expert Review.

Authors:  Enrique Pérez-Cuadrado-Robles; Pierre H Deprez
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

3.  Per Oral Pancreatoscopy Identification of Main-duct Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Duct Stones: Not Mutually Exclusive.

Authors:  Samuel Han; Isaac Raijman; Jorge D Machicado; Steven A Edmundowicz; Raj J Shah
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

4.  Adverse Events Associated With Therapeutic Endoscopic Retrograde Pancreatography.

Authors:  Samuel Han; Augustin R Attwell; Philip Tatman; Steven A Edmundowicz; Hazem T Hammad; Mihir S Wagh; Sachin Wani; Raj J Shah
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.243

5.  Peroral Pancreatoscopy with Videoscopy and Narrow-Band Imaging in Intraductal Papillary Mucinous Neoplasms with Dilatation of the Main Pancreatic Duct.

Authors:  Yui Kishimoto; Naoki Okano; Ken Ito; Kensuke Takuma; Seiichi Hara; Susumu Iwasaki; Kensuke Yoshimoto; Yuto Yamada; Koji Watanabe; Yusuke Kimura; Hiroki Nakagawa; Yoshinori Igarashi
Journal:  Clin Endosc       Date:  2021-12-06

6.  Pancreatic neuroendocrine carcinoma with unique morphological features mimicking intraductal papillary mucinous carcinoma: A case report.

Authors:  Hidekazu Tanaka; Kosuke Minaga; Yasuo Otsuka; Yasuhiro Masuta; Ken Kamata; Kentaro Yamao; Mamoru Takenaka; Tomoko Hyodo; Masatomo Kimura; Tomohiro Watanabe; Masatoshi Kudo
Journal:  Front Med (Lausanne)       Date:  2022-07-13

Review 7.  Pancreatoscopy: An update.

Authors:  Luca De Luca; Alessandro Repici; Adea Koçollari; Francesco Auriemma; Mario Bianchetti; Benedetto Mangiavillano
Journal:  World J Gastrointest Endosc       Date:  2019-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.